Dr. Swati Vishwanathan, MD

Dr. Vishwanathan practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Vishwanathan's NPI, 1851706725, was assigned on June 30, 2014. Dr. Vishwanathan holds West Virginia license 29505.

Dr. Vishwanathan's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Vishwanathan's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Vishwanathan is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Vishwanathan to 3 more hospitals, 1 clinical lab, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vishwanathan practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vishwanathan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vishwanathan is licensed in West Virginia.

CMS data shows 936 Medicare services from Dr. Vishwanathan across 8 procedure codes in 2024, for 270 Medicare patients. Medicare paid $83,282 for them.

CMS counts 270 Medicare patients who saw Dr. Vishwanathan in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vishwanathan's median patient age at 72, with 51% women.

In 2024, Dr. Vishwanathan wrote 1,501 Medicare Part D claims for 277 patients. 79% of them were for generic drugs. CMS names the drug for 1,280 of them, across 40 drugs with 11 or more claims each, at $2,661,754 in total drug cost. In 2023, CMS named 1,033 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Vishwanathan for performance year 2024, reported through an alternative payment model (APM). Dr. Vishwanathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vishwanathan as offering telehealth.

Dmand AI links 8 papers to Dr. Vishwanathan, published from 2016 to 2019. 2016 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Length of Stay and Patient Readmission. Dr. Vishwanathan has published most often in BMJ Case Rep. Dr. Vishwanathan's most frequent co-authors are Rasha Abdulmassih, MD, Briana E. Disilvio, MD and Jina Tushar Makadia, MD.

CMS Open Payments shows 44 general payments to Dr. Vishwanathan from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,212.